Citation Impact
Citing Papers
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis
2011
Delayed Cerebral Ischemia and Spreading Depolarization in Absence of Angiographic Vasospasm after Subarachnoid Hemorrhage
2011
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Heart Rate Variability in Patients With Major Depression
2004
Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control
2016
Action Plan for Stroke in Europe 2018–2030
2018 Standout
The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease
2011 Standout
Therapy for Pulmonary Arterial Hypertension in Adults
2019
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Acute and Chronic Oral Magnesium Supplementation: Effects on Endothelial Function, Exercise Capacity, and Quality of Life in Patients With Symptomatic Heart Failure
2006
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Interleukin-1 Blockade in Acute Decompensated Heart Failure
2016
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
2010
The glymphatic pathway in neurological disorders
2018 Standout
Wound repair and regeneration
2008 StandoutNature
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Assessment of quality of life in severe heart failure
2007
Antithrombotic Therapy for VTE Disease
2016 Standout
Magnesium basics
2012 Standout
Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
2008
Macrophages in immunoregulation and therapeutics
2023 Standout
Systemic sclerosis
2022
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure
2010
Pulmonary Arterial Hypertension in Systemic Sclerosis
2004
Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study*
2010
Systemic sclerosis
2017 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission
2004
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
2012
The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment
2008
Acute respiratory distress syndrome
2019 Standout
Pulmonary Hypertension Associated with Left-Sided Heart Disease
2007
Endothelin—Biology and disease
2010
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Driving Pressure and Survival in the Acute Respiratory Distress Syndrome
2015 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage
2009
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
Cortical spreading depolarization: Pathophysiology, implications, and future directions
2015
Ventilator-Induced Lung Injury
2013 Standout
High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial
2014
Referral of Patients With Pulmonary Hypertension Diagnoses to Tertiary Pulmonary Hypertension Centers
2013
Atherosclerosis
2019 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Structured telephone support or telemonitoring programmes for patients with chronic heart failure
2010
Mechanical Ventilation Guided by Esophageal Pressure in Acute Lung Injury
2008
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
The pathophysiology of acute heart failure—Is it all about fluid accumulation?
2007
Major lung complications of systemic sclerosis
2018
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
The acute respiratory distress syndrome
2012 Standout
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
The impact of health information technology on patient safety
2017 Standout
Ambrisentan, a Non‐peptide Endothelin Receptor Antagonist
2006
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury
2010
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies
2010
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage
2011
Experimental and Preliminary Clinical Evidence of an Ischemic Zone with Prolonged Negative DC Shifts Surrounded by a Normally Perfused Tissue Belt with Persistent Electrocorticographic Depression
2010
Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.
2007 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Remote Ischemic Limb Preconditioning After Subarachnoid Hemorrhage
2011
Endothelin Receptor Blockers in Cardiovascular Disease
2003
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Pathological Ventricular Remodeling
2013
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
1997 Standout
Works of Aline Frey being referenced
Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)
2008
Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)
2005
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
Tezosentan in patients with acute heart failure and acute coronary syndromes: Design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4)
2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure
2003
Neurohormonal Activation in Acute Heart Failure: Results from VERITAS
2011
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure
2007
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)
2011
RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema
2003
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short‐term outcome
2005
Tezosentan in patients with acuteheart failure and acute coronary syndromes
2003
Detecting acute graft rejection in patients after orthotopic heart transplantation: analysis of heart rate variability in the frequency domain.
1998